5 Pharmaceutical Stocks to Buy According to Timothy Lynch’s Stonepine Capital

4. Strongbridge Biopharma plc (NASDAQ:SBBP)

Stonepine Capital’s Stake Value: $9.818 million

Percentage of Stonepine Capital’s 13F Portfolio: 5.13%

Number of Hedge Fund Holders: 12

Founded in 1996 and headquartered in Pennsylvania, Strongbridge Biopharma plc (NASDAQ: SBBP) deals with innovative solutions to cure and manage rare neuromuscular and endocrine conditions. It is ranked fourth on the list of 10 pharmaceutical stocks to buy according to Timothy Lynch’s Stonepine Capital. Strongbridge Biopharma plc (NASDAQ: SBBP) has a market capitalization of $135.658 million.